» Authors » Simon Thebault

Simon Thebault

Explore the profile of Simon Thebault including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 346
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Thebault S, Gandelman S, Lane C, Kim E, Pileggi C, Zuroff L, et al.
Neurol Neuroimmunol Neuroinflamm . 2023 Aug; 10(5). PMID: 37562975
Objectives: The objective of this study was to report on the development of neuroinvasive West Nile virus (WNV) infection in the context of anti-CD20 monotherapy for multiple sclerosis (MS). Methods:...
12.
Thebault S, Bar-Or A, Banwell B
Lancet Neurol . 2023 Jul; 22(9):774-776. PMID: 37524099
No abstract available.
13.
Ulndreaj A, Sohaei D, Thebault S, Pons-Belda O, Fernandez-Uriarte A, Campbell C, et al.
Diagnosis (Berl) . 2023 Feb; 10(3):275-280. PMID: 36788117
Objectives: Neurofilament light (NfL) chain is a marker of neuroaxonal damage in various neurological diseases. Here we quantitated NfL levels in the cerebrospinal fluid (CSF) and serum from patients with...
14.
Meier S, Willemse E, Schaedelin S, Oechtering J, Lorscheider J, Melie-Garcia L, et al.
JAMA Neurol . 2023 Feb; 80(3):287-297. PMID: 36745446
Importance: There is a lack of validated biomarkers for disability progression independent of relapse activity (PIRA) in multiple sclerosis (MS). Objective: To determine how serum glial fibrillary acidic protein (sGFAP)...
15.
Thebault S, Warman-Chardon J, OConnell K, Miller W, Bourque P
Cureus . 2022 Dec; 14(12):e32292. PMID: 36514705
An 83-year-old male developed horizontal diplopia immediately following elective transfemoral transcatheter aortic valve implantation (TAVI). On right gaze, left eye adduction was impaired while there was horizontal nystagmus of the...
16.
Thebault S, Bergman H, Atkins H, Freedman M, Brooks J
Neurol Neuroimmunol Neuroinflamm . 2022 Nov; 10(1). PMID: 36396449
Objective: We report a case of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) who achieved durable and steroid-free remission after IV cladribine. Methods: A 25 year-old...
17.
Reilly A, Deguise M, Beauvais A, Yaworski R, Thebault S, Tessier D, et al.
Gene Ther . 2022 Apr; 29(9):544-554. PMID: 35462564
Spinal muscular atrophy (SMA) is a neuromuscular disease caused by loss of the SMN1 gene and low SMN protein levels. Although lower motor neurons are a primary target, there is...
18.
Thebault S, Kim W, Hadwen J, Walker G, Drake B, Fantaneanu T
Neurohospitalist . 2022 Apr; 12(2):318-322. PMID: 35419159
We present the case of a 73-year-old woman with a 3-month history of non-traumatic thoracic myelopathy. Initial MRI showed a T6-conus T2 signal hyperintensity. Based on this presentation, and given...
19.
Berard J, Freedman M, Marrie R, Marriott J, Atkins H, Szwajcer D, et al.
Mult Scler Relat Disord . 2022 Apr; 61:103779. PMID: 35367874
Background: Mesenchymal stem cell (MSC) therapies are being evaluated in multiple sclerosis (MS) for possible neural repair. To date, the potential benefits on cognition have received little attention. The objective...
20.
Thebault S, Reaume M, Marrie R, Marriott J, Furlan R, Laroni A, et al.
Mult Scler Relat Disord . 2022 Jan; 59:103535. PMID: 35078125
Background: One-off serum levels of neurofilament light chain (sNfL) is an established predictor of emerging disease activity in multiple sclerosis (MS). However, the importance of longitudinal increases in sNfL is...